CanSino Biologics

CanSino Biologics CASBF Stock

$3.10   -9.090915%
Add to favorites
Market Cap
$765.84M
LOW - HIGH [24H]
$3.41 - $3.55
VOLUME [24H]
$1.30K
P/E Ratio
155.00
Earnings per share
$0.02
ISIN
CNE100003F01
Price   Prediction

CanSino Biologics Price Chart

Sorry, that's all we've gotfor now...

CanSino Biologics (CASBF) stock price today is 3.1 USD on OTC Markets OTCPK (-9.09% on the day). Updated .

CanSino Biologics CASBF Financial and Trading Overview

CanSino Biologics stock price 3.1 USD
Previous Close 3.41 USD
Open 3.55 USD
Bid 2.9 USD x 30000
Ask 3.2 USD x 10000
Day's Range 3.41 - 3.55 USD
52 Week Range 2.6 - 5.6 USD
Volume 1.3K USD
Avg. Volume 132 USD
Market Cap 765.84M USD
Beta (5Y Monthly) 1.17
PE Ratio (TTM) 155
EPS (TTM) 0.02 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date July 13, 2022
1y Target Est N/A

CASBF Valuation Measures

Enterprise Value -124468336 USD
Trailing P/E 155
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.6089442
Price/Book (mrq) 1.0324363
Enterprise Value/Revenue -0.099
Enterprise Value/EBITDA -1.707

Trading Information

CanSino Biologics Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change -44.64%
S&P500 52-Week Change 13.32%
52 Week High 5.6 USD
52 Week Low 2.6 USD
50-Day Moving Average 3.79 USD
200-Day Moving Average 3.67 USD

CASBF Share Statistics

Avg. Volume (3 month) 132 USD
Avg. Daily Volume (10-Days) 100 USD
Shares Outstanding 132.67M
Float 150.76M
Short Ratio N/A
% Held by Insiders 26.31%
% Held by Institutions 14.18%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 2.36%
Operating Margin (ttm) -5.37%
Gross Margin 74.07%
EBITDA Margin 5.79%

Management Effectiveness

Return on Assets (ttm) -0.59%
Return on Equity (ttm) 0.59%

Income Statement

Revenue (ttm) 1.26B USD
Revenue Per Share (ttm) 5.08 USD
Quarterly Revenue Growth (yoy) 7.19%
Gross Profit (ttm) 931.62M USD
EBITDA 72.9M USD
Net Income Avi to Common (ttm) 29.72M USD
Diluted EPS (ttm) 0.02
Quarterly Earnings Growth (yoy) -39.10%

Balance Sheet

Total Cash (mrq) 1.78B USD
Total Cash Per Share (mrq) 7.63 USD
Total Debt (mrq) 929.56M USD
Total Debt/Equity (mrq) 18.56 USD
Current Ratio (mrq) 4.229
Book Value Per Share (mrq) 3.0026066

Cash Flow Statement

Operating Cash Flow (ttm) 33.63M USD
Levered Free Cash Flow (ttm) -401329952 USD

Profile of CanSino Biologics

Country United States
State N/A
City Tianjin
Address 401-420, Biomedical Park
ZIP 300457
Phone 86 022 5821 3600
Website https://cansinotech.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 1134

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; and CS-2023 to treat meningitis. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

Q&A For CanSino Biologics Stock

What is a current CASBF stock price?

CanSino Biologics CASBF stock price today per share is 3.1 USD.

How to purchase CanSino Biologics stock?

You can buy CASBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CanSino Biologics?

The stock symbol or ticker of CanSino Biologics is CASBF.

Which industry does the CanSino Biologics company belong to?

The CanSino Biologics industry is Drug Manufacturers - Specialty & Generic.

How many shares does CanSino Biologics have in circulation?

The max supply of CanSino Biologics shares is 247.04M.

What is CanSino Biologics Price to Earnings Ratio (PE Ratio)?

CanSino Biologics PE Ratio is 155.00000000 now.

What was CanSino Biologics earnings per share over the trailing 12 months (TTM)?

CanSino Biologics EPS is 0.02 USD over the trailing 12 months.

Which sector does the CanSino Biologics company belong to?

The CanSino Biologics sector is Healthcare.

$2.19T
Total marketcap
$71.47B
Total volume
BTC 59.40%   •   ETH 10.13%
Dominance
Select currency